{
    "code": "02009714",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02009714",
    "time": "2019-03-29 03:03:35",
    "許可證字號": "衛署藥輸字第009714號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/03\/12",
    "發證日期": "103\/01\/22",
    "許可證種類": "製　劑",
    "舊證字號": "02004147",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200971402",
    "中文品名": "隆我心注射劑",
    "英文品名": "LANOXIN DIGOXIN INJECTION 0.5MG B.P.",
    "適應症": "心臟衰竭、心房撲動、心房纖維顫動、陣發性上心室性心搏過速",
    "劑型": "270注射劑",
    "包裝": "2ML安瓿 5AMP盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DIGOXIN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "6401022326  安沛國際有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250339000  GLAXOSMITHKLINE MANUFACTURING S.P.A.",
        "製造廠廠址": "STRADA PROVINCIALE ASOLANA,90 SAN POLO DI TORRILE 43056 PARMA, ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2404100900",
            "成分名稱": "DIGOXIN",
            "含量描述": "",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lanoxin Inj仿單_DIG-1901-01 CCDS v20-108-02-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009714&Seq=004&Type=9"
        },
        {
            "title": "020097140003-103-06-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02009714&Seq=002&Type=8"
        }
    ]
}